Zhong Yuan Bio-Technology Holdings Limited
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sell… Read more
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) - Net Assets
Latest net assets as of September 2024: $-218.79K USD
Based on the latest financial reports, Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) has net assets worth $-218.79K USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.17 Million) and total liabilities ($3.39 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-218.79K |
| % of Total Assets | -6.91% |
| Annual Growth Rate | N/A |
| 5-Year Change | -114.58% |
| 10-Year Change | N/A |
| Growth Volatility | 55.88 |
Zhong Yuan Bio-Technology Holdings Limited - Net Assets Trend (2018–2025)
This chart illustrates how Zhong Yuan Bio-Technology Holdings Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Zhong Yuan Bio-Technology Holdings Limited (2018–2025)
The table below shows the annual net assets of Zhong Yuan Bio-Technology Holdings Limited from 2018 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $-218.79K | 0.00% |
| 2024-03-31 | $-218.79K | +33.69% |
| 2023-03-31 | $-329.94K | -135.05% |
| 2022-03-31 | $941.40K | -37.26% |
| 2021-03-31 | $1.50 Million | +1.40% |
| 2020-03-31 | $1.48 Million | +1.91% |
| 2019-03-31 | $1.45 Million | +5571.05% |
| 2018-03-31 | $-26.54K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Zhong Yuan Bio-Technology Holdings Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 321281900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $17.71K | % |
| Other Comprehensive Income | $179.19K | % |
| Other Components | $2.81 Million | % |
| Total Equity | $-204.55K | 100.00% |
Zhong Yuan Bio-Technology Holdings Limited Competitors by Market Cap
The table below lists competitors of Zhong Yuan Bio-Technology Holdings Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Excel Force MSC Bhd
KLSE:0065
|
$7.15 Million |
|
An Pha Petroleum Group JSC
VN:ASP
|
$7.15 Million |
|
Kantone Holdings Limited
PINK:KTHGF
|
$7.15 Million |
|
NICAN Limited
V:NICN
|
$7.16 Million |
|
Tsky Co.,Ltd
TWO:6784
|
$7.15 Million |
|
Alset Ehome International Inc
NASDAQ:AEI
|
$7.15 Million |
|
Kirkstone Metals Corp.
V:KSM
|
$7.14 Million |
|
Talisman Mining Ltd
F:RJA
|
$7.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhong Yuan Bio-Technology Holdings Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -204,549 to -204,549, a change of 0.
- Net income of 302,210 contributed positively to equity growth.
- Other comprehensive income increased equity by 179,191.
- Other factors decreased equity by 481,401.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $302.21K | +147.74% |
| Other Comprehensive Income | $179.19K | +87.6% |
| Other Changes | $-481.40K | -235.35% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Zhong Yuan Bio-Technology Holdings Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | $0.00 | $2.00 | x |
| 2018-03-31 | $0.00 | $2.00 | x |
| 2019-03-31 | $0.05 | $2.00 | x |
| 2020-03-31 | $0.09 | $2.00 | x |
| 2021-03-31 | $0.09 | $2.00 | x |
| 2022-03-31 | $0.05 | $2.00 | x |
| 2023-03-31 | $-0.02 | $2.00 | x |
| 2024-03-31 | $-0.01 | $2.00 | x |
| 2025-03-31 | $-0.01 | $2.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhong Yuan Bio-Technology Holdings Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.27%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-12.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.67K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-24.54K |
| 2019 | 19.30% | 23.01% | 0.65x | 1.29x | $134.98K |
| 2020 | -5.90% | -7.16% | 0.54x | 1.54x | $-235.28K |
| 2021 | -1.87% | -1.71% | 0.47x | 2.30x | $-178.07K |
| 2022 | -119.56% | -48.34% | 0.82x | 3.03x | $-1.22 Million |
| 2023 | 0.00% | -134.19% | 0.73x | 0.00x | $-2.20 Million |
| 2024 | 0.00% | 13.27% | 0.72x | 0.00x | $322.66K |
| 2025 | 0.00% | 13.27% | 0.72x | 0.00x | $322.66K |
Industry Comparison
This section compares Zhong Yuan Bio-Technology Holdings Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $4,768,351,202
- Average return on equity (ROE) among peers: -224.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) | $-218.79K | 0.00% | N/A | $7.15 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $-46.26 Million | 0.00% | 0.00x | $18.58 Million |
| The a2 Milk Company Limited (ACOPF) | $58.64 Million | 0.02% | 0.31x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $668.89K | -63.57% | 1.39x | $90.84 |
| Alfa S.A.B. de C.V (ALFFF) | $43.29 Billion | 8.20% | 1.29x | $2.16 Billion |
| Amincor Inc (AMNCB) | $1.83 Million | -1769.92% | 18.32x | $2.21K |
| Armanino Foods New (AMNF) | $5.68 Million | 50.87% | 0.65x | $71.04K |
| Amira Nature Foods Ltd (ANFIF) | $171.84 Million | 17.43% | 1.45x | $128.79 |
| AAK AB (publ.) (ARHUF) | $3.56 Billion | 16.89% | 1.80x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $9.48K | -513.58% | 0.36x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |